NEGATIVE ION SPECTACLE

CLINICAL TEST REPORT(1)

Invention Patent Right:

发明专利号: 20111002045.X

Design Patent Right: 201230010843.1

产品专利号: 201230010843.1

Utility Patent Right

实用新型专利::201220634648-0
ABSTRACT:

The primary goals of the studies are to verify the effectiveness of negative Ionspec
could help to improve visual acuity in the subjects study. And, verify the non-side
effect of the negative Ionspec.Aging and genetic factors causes’ macular
degeneration , and leading to blindness in the population.Visual problems such as:
Asthenopia(A), myopic, astigmatism, presbyopia, cataract and age-related macular
degeneration can lead to severe central vision loss (Glaucoma) that is related to
aging-associated eye problems. Early prevention with antioxidants is mandatory.
The aim of this study was to determine whether and how negative ions Spec can act
as solid supply of antioxidant.
Sample Grouping

Group Sample
A. Patients with minor or minimum eye's 1. Female, 40 y/o
diseases: 2. Female, 61 y/o
3. Male, 74 y/o
B. Patients with middle stage of eye's 1. Male, ? y/o
diseases 2. Female, 10 y/o
C. Patients with chronic stage eye's 1. Male, x y/o, Glaucoma
diseases
D. Patients who are blind, as control 1. Female, x y/o
group

Result Capture Method:

1. Snellen chart or equipment.

 2. Psychology vision measure was performing by observing the subjects
behaviours.
Result: Group A on Snellen chart

10 subjects with common visual problems including asthenopia(1), myopia,

presbyopia, hyperopia , Glaucoma, Cataract, floaters and astigmatism were recruited
from Taipei T&CM Medical Centre. Each individual had measure their vision acuity
or stated vision problems(2). Visual acuity of this subjects uses as vision parameter
in this study. The visions of the subjects in this study were measured by Snellen
chart or equipment. Secondary psychology vision measure was performing by
observing the subjects behaviors.

Research subjects are divided into four major categories listed as below:

Group A) Patients with minor or minimum eye's diseases: Purpose to verify the
Negative IonSpec is safe, non-side effects. Expecting that after 1 year of wearing
Negative IonSpec that subjects would not have visual deteriorate then the before the
study. Hence, subject’s visual acuity should be category in healthy stage before the
study.
Subject 1(Female,40): SPH CYL AX

R -1.5 -0.5 29

L -0.75 -0.5 124

Date:2nd Dec 2012

Subject: A2( Mdm Tan, 61)

Visual problems: Mild Myopia, mild Presbyopia/Hyperopia

R +0.37 -0.50 120

S.E.+0.12

L +1.12 -1.25 20

S.E.+0.5

Date: 16th Dec 2012

After 3 months of using Negative IonSpec,Test result on her vision : her visual acuity
has improves by 22% on her left eye. Right eye visual acuity under neurological
transitions:

R - 0.12 -0.37 130

+0.00 -0.25 125

S.E. -0.12

L +0.87 -0.87 20

S.E. +0.37

Date : 26th Feb 2012

Subject A3: (Mr.Ping,74)

R +0.87 -0.5 70

SE+0.62

L +1.75 -0.62 125

SE+1.73

Date: 16th Dec 2012

Group B Result: on Snellen Chart

Group B) Patients with middle stage of eye's diseases: To proven IonSpec can
help with vision or eye's sight improvement.
Subject B1) Mr.Ong

Subject with complex visual problems (due to accident impact on his eye): Myopic
vision has improved 10% in the beginning of 2 weeks ( 30th Dec 2012). After 3
months, his asthenopia(1),glare, blurred vision, floaters has reduces to clear.
Suggesting after 3 months of negative ions spec, he still experiencing neurological
transition, where hismyopic vision mildly reduce to beginning stage(measured by
Snellen chart), but floaters was gone. Therefore, overall vision has improved as his
statement was provided by interview method.

Subject B2: Ms.X (age 10) Myopic and astigmatism problems.

Date: 5th Dec 2012

Group C Result: on Snellen chart

Group C) Patients with chronic stage eye's diseases: To prove that IonSpec can
help with patient with significant eye's problem.
Subject C1: Mr.Lim Pia Kim( 0492) vision remain 15%, glaucoma.
His eye pressure was reduced after 3 weeks of wearing Negative Ions Spec,
together with acupuncture, herbal treatment.

Group D Result: on Snellen chart

Group D) Patients who are blind, as control group.
Subject: Madam Thong(016-6299921)
Vision 5-10%, a virtually blind patient. Started using Neg Ion Spec on 31/12/12
Secondary psychology vision measure was performing by observing the subjects
behaviours. The user referral the negative ions spec to their peer. On assumption of
the negative ions spec does help with vision improvement that the studies subjects
welling to share the aid to their peer.

Conclusion: 10 subjects expressed satisfaction with the Negative Ions Spec provided
and the improvement obtained. The results of the evaluation suggest that the
effectiveness of negative IonSpec could help to improve visual acuity in the subjects.
Foot Notes:

Asthenopia : weakness or easy fatigue of the eye, with pain in the eyes, headache,
dimness of vision.

Reference:

(1) Optom Vis Sci. 2003 Nov;80(11):732-9. Is all asthenopia the same? Sheedy JE,
Hayes JN, Engle J.The Ohio State University, College of Optometry, Columbus,
OH 43218, USA. sheedy2@osu.edu

(2) CLINICAL EVALUATION OF THE SEE CLEARLY METHOD-

 http://www.strong-eyes.com/RESEARCH%20MASTER.pdf

(3) Snellen Chart http://en.wikipedia.org/wiki/Snellen_chart

(4) Ionspec Website: www.Ionspec.net

 NEGATIVE ION SPECTACLE
CLINICAL TEST REPORT(2)

Invention Patent Right:

发明专利号: 20111002045.X

Design Patent Right: 201230010843.1

产品专利号: 201230010843.1

Utility Patent Right

实用新型专利::201220634648-0
ABSTRACT:
The primary goals of the studies are to verify the effectiveness of negative IonSpec
could help to improve visual acuity in the subject study. This test is to study non-side
effect of the negative IonSpec. The causes for blindness in the population are: Aging
and macular degeneration. Visual problems such as: Asthenopia(A), myopic,
astigmatism, presbyopia, cataract and age-related macular degeneration can lead to
severe central vision loss (Glaucoma)(1). Visual problems are aging-associated eye
problems. Early prevention with antioxidants is mandatory. The aim of this study was to
determine negative IonSpec can act as solid supply of antioxidant(1).

Subjects Grouping

Grouping (Experimental, A-D) Subjects

A. Patients with minor or minimum eye's 1. F, 40
diseases: 2. F, 61
3. M, 74
4. F, 30
5. F,35
B. Patients with middle stage of eye's 1. M, 55
diseases 2. F, 10
3. F,46
4. F, 47
5. M,63
6. M,70
C. Patients with chronic stage eye's 1. M, 75 , Glaucoma
diseases or Patients who are blind. 2. F, x y/o
D. Control Group, patient no using Neg 1. F, 33y/o
IonSpec 2.

Result Capture Method:

1. Snellen chart or equipment.

 2. Psychology vision measure was performing by observing the subjects behaviors.
Result: Group A on visual acuity test improvement (%) compared to initial visions:

0.6

0.5

0.4
sub1®
0.33 sub(l)
0.3
sub2 (l)
sub4
0.2
sub5

0.1

0 0
Initial Stage
12th weeks
24th weeks
36th weeks48 weeks 60weeks

10 subjects with common visual problems including asthenopia(1), myopia,

presbyopia, hyperopia , Glaucoma, Cataract, floaters and astigmatism were
recruited from Taipei T&CM Medical Centre. Individual's vision acuity or
stated vision problems were measured (2). The parameter is visual acuity of
participant subjects. A Snellen chart or equipment was used to measured
subjects visions. The observing subject’s behaviours as secondary
psychology to determinate vision were measured.

Research subjects are divided into four major groups as listed:

Group A) Patients with minor or minimum eye's diseases: Purpose to verify the
Negative IonSpec is safe, non-side effects. Expecting that after 1 year of wearing
Negative IonSpec that subjects would not have visual deteriorate then the before the
study. Hence, subject’s visual acuity should be category in healthy stage before the
study.

Subject 1(Female,40): SPH CYL AX

R -1.5 -0.5 29
L -0.75 -0.5 124

Date:2nd Dec 2012

R -1.25 -0.5

L -0.5 -0.25

Date: 7th March 2013

After 3 months using negative IonSpec, patient’s right eyes have improving by 16% on
visual acuity test. Patient’s Left eye vision acuity test improving by 33%. On the
astigmatism right eye remain the same, but left eye’s improving by 50%.

Subject: A2( Mdm Tan, 61)

Visual problems: Mild Myopia, mild Presbyopia/Hyperopia

S C

R +0.37 -0.50 120

S.E.+0.12

L +1.12 -1.25 20

S.E.+0.5

Date: 16th Dec 2012

After 3 months of using Negative IonSpec,Test result on her vision : her visual acuity
has improves by 22% on her left eye. Right eye visual acuity under neurological
transitions:

S C
R - 0.12 -0.37 130

+0.00 -0.25 125

S.E. -0.12

L +0.87 -0.87 20

S.E. +0.37

Date : 26th Feb 2013

Mdm Tan testing her eyes on other equipment:

S C

R +0.25 -0.50 100

S.E. +0.00

S C

L +1.25 -1.0 15

S.E. +0.75

Date: 8th/May 2013 Patient’s left eyes( to be continue)

Subject A3: (Mr.Ping,74)

R +0.87 -0.5 70

SE+0.62

L +1.75 -0.62 125

SE+1.73

Date: 16th Dec 2012

A4) Female, 30 Myopic problem.

A5) Celestine, 35,F. Used IonSpec two to three weeks, my myopia dropped from

50 degrees to 25 degrees.

Group B result: In progressing. Result in writing.

2.5

2.2
2

1.5 1.5 1.5 subB1

Sub B2
1 sub B3
sub B4

0.5

0.2
0
Initial Stage 4th weeks 8th weeks 12th weeks 16th weeks

Group B) Patients with middle stage of eye's diseases: To proven IonSpec can help
with vision or eye's sight improvement.

Subject B1)Mr.Ong(using high level energy IonSpec): Subject with complex visual
problems (due to accident impact on his eye): Myopic vision has improved 10% in
the beginning of 2 weeks ( 30th Dec 2012). He reported having clear vision after 3
months wearing IonSpec. His asthenopia(1),glare, blurred vision, floaters has
reduced. Suggest that he still experiencing neurological transition, where his
myopic problem mildly reduce to beginning stage (measured by Snellen chart).
But,floaters was gone. Therefore, overall vision has improved as his statement was
provided by interview method.

4.9 can read clearly on Snelle Chart Date: 11/4/13.

4.9 can read clearly on Snelle Chart. Date: 13/5/13.

Subject B2: Ms.X (age 10) Myopic and astigmatism problems.

B3, Michelle,46 y/o Test on Snelle Chat.(( ½ distant from normal distant )) . 4.2 can
read. 4.3 can not read. Date: 12/3/13, After 1 month, re-measure 4.4 can read.
Improvement on 17/4/13. Maintaining 4.4 can read. Date 10/5/13.

Subject B4: Ms.Maggie (Female, 47)

SPH CYL

Right +1.00 -4.5

Left +1.00 - 3.5

Date: 3rd Feb 2013

B5) Mr.Fong, 63 y/o, Snelle Chart 4.8 can read. 4.9 Can not read. Date 30/12/12

B6) Jiao Yang,70. I wear the IonSpec 3 and a half months- after my presbyopia

reduced 75 degrees (the original 275 degrees, 200 degrees now). There, my
floaters previous daily stop now rarely. Read newspapers can only see half an

hour before, and now look at the newspapers of the time can be as long as
several hours, the eyes will not feel tired. And after wearing IonSpec, my spirit a
lot, can drive up, not easy fatigue. Thank IonSpec so good product. Date: 5th Dec
2013
B7)1.5 square block: Kam Yee Woon,F, 19

Both eyes: 4.35 can read on chart

Left eye : 4.1 can read on chart

Right eye :4.2 can read on chart

Date:April 6th 13
------------------------------------------
B8)1.5 square block: Ng Kim Yoong, F,26

Both eyes: 4.35 can read on chart

L: 4.1 can read on chart

R: 4.2 can read on chart

Date: April 6th 13

Group C) Patients with chronic stage eye's diseases: To prove that IonSpec can help
with patient with significant eye's problem.
Subject C1: Mr.Lim Pia Kim( 0492) vision remain 15%, glaucoma.

His eye pressure was reduced after 3 weeks of wearing Negative Ions Spec, together
with acupuncture, herbal treatment.
Group D) Patients who are blind.

Subject: Madam Thong(016-6299921)

Vision 5-10%, a virtually blind patient. Started using Neg Ion Spec on 31/12/12
Group E.1) Ah Fan,Patient as Control group, Not Using negative IonSpec. Female,33
y/o.
SPH CYL
R - 4.00
L - 3.50
E.2)

Secondary psychology vision measure was performing by observing the subjects

behaviours. The user referral the negative ions spec to their peer. On assumption of the
 negative ions spec does help with vision improvement that the studies subjects welling
to share the aid to their peer.

Conclusion: Ten subjects expressed satisfaction; their vision improvement with the
Negative Ions Spec provided. The results of the evaluation suggest that the
effectiveness of negative IonSpec could help to improve visual acuity in the
subjects. The control group, who do not wear IonSpec , estimating their vision
remain same or worsen after 3-6 months. Comparing the experimental groups
(patients who wearing IonSpec) and control group (Not-wearing IonSpec). Those
experimental groups' visual acuity has improved. Therefore, we
suggest IonSpec provide positive effects in helping patients vision.

All the subjects studies are patients recruited from Taipei TCM Medical Center,Kepong
Sdn.Bhd. All subjects also undertaking other medical treatments, supplements and
herbal prescription.

Researchers Profile:

1. Professor Dr.Chu Yun Sang. PPN. PJK. President of Taipei TCM Medical Centre Sdn.
Bhd. United States Golden University, Doctor of Philosophy. BSc(TCM).

2. Saw Lay San. Research Conductor, Taipei TCM Medical Centre Sdn.Bhd. University of
Lethbridge, Canada.Bio-Psychological Science Study. Su-Chen TCM Clinic Trail,
Manitoba, Canada. PPL Canada, CPL(T) Malaysia.

3. Foot Notes:

A. Asthenopia : weakness or easy fatigue of the eye, with pain in the eyes, headache,
dimness of vision.

Reference:

(1) Optom Vis Sci. 2003 Nov;80(11):732-9. Is all asthenopia the same? Sheedy JE,
Hayes JN, Engle J.The Ohio State University, College of Optometry, Columbus, OH
43218, USA. sheedy2@osu.edu
(2) CLINICAL EVALUATION OF THE SEE CLEARLY METHOD- http://www.strong-
eyes.com/RESEARCH%20MASTER.pdf
(3) Snellen Chart http://en.wikipedia.org/wiki/Snellen_chart

(4) Ionspec Website: www.Ionspec.net , www.ionspeconline.com, www.Ionic.com.my

(5) http://www.nlm.nih.gov/medlineplus/ency/article/003434.htm
(6) http://www.selectspecs.com/info/help-with-prescription/